Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.5400 (5.99%) ($3.5400 - $3.5400) on Mon. Jan. 31, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.5% (three month average) | RSI | 23 | Latest Price | $3.5400(5.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.6% a day on average for past five trading days. | Weekly Trend | CGEN declines -7.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(87%) ARKG(82%) ARKK(82%) IWO(82%) BLOK(81%) | Factors Impacting CGEN price | CGEN will decline at least -2.25% in a week (0% probabilities). VIXM(-73%) VXX(-53%) UUP(-28%) UNG(-13%) EDOC(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.25% (StdDev 4.5%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.28(-475.14%) | Resistance Level | $3.86 | 5 Day Moving Average | $3.46(2.31%) | 10 Day Moving Average | $3.59(-1.39%) | 20 Day Moving Average | $3.86(-8.29%) | To recent high | -50.6% | To recent low | 6.6% | Market Cap | $293m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |